1H NMR metabolic profiling of gastric cancer patients with lymph node metastasis

作者：Hailong Zhang, Longzhen Cui, Wen Liu, Zhenfeng Wang, Ye Yang, Xue Li, Huijuan Wang · 发表于：Metabolomics · 年份：2018 · DOI：10.1007/s11306-018-1344-x · 被引用次数：23 · 研究领域：Metabolomics and Mass Spectrometry Studies、Cancer, Hypoxia, and Metabolism、Diet, Metabolism, and Disease

INTRODUCTION: Gastric cancer (GC) is a malignant tumor worldwide. As primary pathway for metastasis, the lymphatic system is an important prognostic factor for GC patients. Although the metabolic changes of gastric cancer have been investigated in extensive studies, little effort focused on the metabolic profiling of lymph node metastasis (LNM)-positive or negative GC patients. OBJECTIVES: H NMR spectrum of GC tissue samples with and without LNM to identify novel potential metabolic biomarkers in the process of LNM of GC. METHODS: H NMR-based untargeted metabolomics approach combined with multivariate statistical analyses were used to study the metabolic profiling of tissue samples from LNM-positive GC patients (n = 40), LNM-negative GC patients (n = 40) and normal controls (n = 40). RESULTS: There was a clear separation between GC patients and normal controls, and 33 differential metabolites were identified in the study. Moreover, GC patients were also well-classified according to LNM-positive or negative. Totally eight distinguishing metabolites were selected in the metabolic profiling of GC patients with LNM-positive or negative, suggesting the metabolic dysfunction in the process of LNM. According to further validation and analysis, especially BCAAs metabolism (leucine, isoleucine, valine), GSH and betaine may be as potential factors of diagnose and prognosis of GC patients with or without LNM. CONCLUSION: To our knowledge, this is the first metabolomics study focusing on...